We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-15.8%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$537M
AUM Growth
-$133M
Cap. Flow
-$47.6M
Cap. Flow %
-8.86%
Top 10 Hldgs %
11.25%
Holding
1,208
New
454
Increased
145
Reduced
142
Closed
463

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$10.5M
2
TFC icon
Truist Financial
TFC
+$8.46M
3
QCOM icon
Qualcomm
QCOM
+$8.04M
4
WBA
Walgreens Boots Alliance
WBA
+$4.59M
5
EOG icon
EOG Resources
EOG
+$4.52M

Sector Composition

Rank Sector Weight
1 Technology 20.77%
2 Healthcare 13.14%
3 Consumer Discretionary 12.35%
4 Industrials 11.65%
5 Financials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLD icon
351
Prologis
PLD
$137B
$470K 0.09%
+3,991
New +$552K
FROG icon
352
JFrog
FROG
$9.84B
$465K 0.09%
+22,092
New +$463K
VSXY
353
Victoria's Secret
VSXY
$6.78B
$464K 0.09%
+16,600
New +$719K
CAL icon
354
Caleres
CAL
$420M
$462K 0.09%
+17,602
New +$436K
BMBL icon
355
Bumble
BMBL
$386M
$461K 0.09%
+16,364
New +$444K
WMB icon
356
Williams Companies
WMB
$86.6B
$460K 0.09%
+14,737
New +$509K
LOGC
357
DELISTED
ContextLogic
LOGC
$458K 0.09%
+9,532
New +$516K
ATC
358
DELISTED
Atotech Limited
ATC
$458K 0.09%
23,681
+1,200
+5% +$24.8K
BRKR icon
359
Bruker
BRKR
$9.14B
$456K 0.08%
+7,269
New +$446K
DOC icon
360
Healthpeak Properties
DOC
$15.5B
$456K 0.08%
+17,600
New +$533K
DB icon
361
Deutsche Bank
DB
$67.9B
$452K 0.08%
51,726
+18,324
+55% +$196K
CTAS icon
362
Cintas
CTAS
$84.4B
$450K 0.08%
4,816
+1,744
+57% +$170K
NEWR
363
DELISTED
New Relic, Inc.
NEWR
$450K 0.08%
+9,000
New +$500K
SJM icon
364
J.M. Smucker
SJM
$12.9B
$448K 0.08%
+3,500
New +$467K
TMHC icon
365
Taylor Morrison
TMHC
$444K 0.08%
+19,002
New +$503K
CVET
366
DELISTED
Covetrus, Inc. Common Stock
CVET
$444K 0.08%
+21,400
New +$381K
KRE icon
367
State Street SPDR S&P Regional Banking ETF
KRE
$4.47B
$441K 0.08%
+7,600
New +$475K
ALK icon
368
Alaska Air
ALK
$5.3B
$439K 0.08%
10,961
+6,567
+149% +$321K
FNF icon
369
Fidelity National Financial
FNF
$14B
$439K 0.08%
+12,352
New +$483K
UNFI icon
370
United Natural Foods
UNFI
$2.97B
$437K 0.08%
+11,100
New +$466K
SWBI icon
371
Smith & Wesson
SWBI
$666M
$431K 0.08%
+32,800
New +$476K
BILI icon
372
Bilibili
BILI
$7.47B
$428K 0.08%
16,716
-1,022
-6% -$24.6K
CVNA icon
373
Carvana
CVNA
$45.9B
$427K 0.08%
+94,605
New +$995K
APAM icon
374
Artisan Partners
APAM
$2.86B
$424K 0.08%
+11,919
New +$434K
BBVA icon
375
Banco Bilbao Vizcaya Argentaria
BBVA
$147B
$424K 0.08%
93,900
+39,200
+72% +$199K

Similar funds

Bayesian Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bayesian Capital Management held 1,208 positions worth $537M, down 20% from $670M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bayesian Capital Management withdrew a net $47.6M in Q2 2022, closing 463 positions and reducing 142 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $35.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bayesian Capital Management opened a new position in T-Mobile US worth $10.8M.

  • Bayesian Capital Management's largest Q2 2022 buy was T-Mobile US: 80,110 shares worth $10.8M.
  • Bayesian Capital Management added most to iShares Russell 2000 ETF in Q2 2022, an estimated $4.26M increase.
  • Bayesian Capital Management's biggest Q2 2022 reduction was Verizon, cutting an estimated $4.51M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $35.6M.
  • Bayesian Capital Management's ten largest holdings make up 11% of its $537M portfolio in Q2 2022.
  • Bayesian Capital Management opened 454 new positions and closed 463 in Q2 2022.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $537M.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.